software analysis suite Search Results


90
ChemInnovation Software Inc cbis data analysis suite
Cbis Data Analysis Suite, supplied by ChemInnovation Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/cbis+data+analysis+suite/pmc06863850-300-5-9
Average 90 stars, based on 1 article reviews
cbis data analysis suite - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Partek software analysis suite
Software Analysis Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/software+analysis+suite/pmc04342186-114-10-10
Average 90 stars, based on 1 article reviews
software analysis suite - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Qognit Inc legendplex data analysis software suite
PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of <t>LEGENDplex</t> proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.
Legendplex Data Analysis Software Suite, supplied by Qognit Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/legendplex+data+analysis+software+suite/pmc11552574-283-14-19
Average 90 stars, based on 1 article reviews
legendplex data analysis software suite - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Visiopharm AS software-based image analyzing system vis software suite
PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of <t>LEGENDplex</t> proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.
Software Based Image Analyzing System Vis Software Suite, supplied by Visiopharm AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/image+analysis+software+vis+software+suite/pm36131941-101-7-13
Average 90 stars, based on 1 article reviews
software-based image analyzing system vis software suite - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ChemInnovation Software Inc chemical and biological information systems data analysis suite cbis
PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of <t>LEGENDplex</t> proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.
Chemical And Biological Information Systems Data Analysis Suite Cbis, supplied by ChemInnovation Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/chemical+and+biological+information+systems+data+analysis+suite+cbis/pmc06606843-74-7-14
Average 90 stars, based on 1 article reviews
chemical and biological information systems data analysis suite cbis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Konan Medical USA analysis suite software
PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of <t>LEGENDplex</t> proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.
Analysis Suite Software, supplied by Konan Medical USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/analysis+suite+software/pmc08807987__mmc6-218-18-22
Average 90 stars, based on 1 article reviews
analysis suite software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
AYOXXA Inc lunaris analysis suite software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Lunaris Analysis Suite Software, supplied by AYOXXA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/lunaristm+analysis+suite+software/pmc08962359-62-6-12
Average 90 stars, based on 1 article reviews
lunaris analysis suite software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
VIDA Diagnostics vida pulmonary workstation software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Vida Pulmonary Workstation Software, supplied by VIDA Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/pulmonary+analysis+software+suite/pmc04216374-116-12-16
Average 90 stars, based on 1 article reviews
vida pulmonary workstation software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Qognit Inc legendplextm data analysis software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Legendplextm Data Analysis Software, supplied by Qognit Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/legendplextm+data+analysis+software+suite/pm37655977-120-17-22
Average 90 stars, based on 1 article reviews
legendplextm data analysis software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Softworx Inc suite visualization and analysis software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Suite Visualization And Analysis Software, supplied by Softworx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/suite+visualization+and+analysis+software/pmc05210157-376-10-6
Average 90 stars, based on 1 article reviews
suite visualization and analysis software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Philips Healthcare dedicated workstation software for quantitative analysis of angiograms philips inturis suite r2.2
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Dedicated Workstation Software For Quantitative Analysis Of Angiograms Philips Inturis Suite R2.2, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/angiography+viewing+workstation+software+for+quantitative+analysis+philips+inturis+suite++r2+2/pm16802000-61-21-22
Average 90 stars, based on 1 article reviews
dedicated workstation software for quantitative analysis of angiograms philips inturis suite r2.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation earray expression analysis suite 2.0 software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Earray Expression Analysis Suite 2.0 Software, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+analysis+suite/earray+expression+analysis+suite+2+0+software/pm19185596-108-13-19
Average 90 stars, based on 1 article reviews
earray expression analysis suite 2.0 software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of LEGENDplex proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.

Journal: Journal for Immunotherapy of Cancer

Article Title: In situ endoscopic photodynamic therapy combined with immature DC vaccination induces a robust T cell response against peritoneal carcinomatosis

doi: 10.1136/jitc-2024-009752

Figure Lengend Snippet: PDT induces ferroptosis and immunogenic cell death. ( A–F ) CT26 colorectal carcinoma and AB12 mesothelioma two-dimensional (2D) cell cultures and 3D spheroids were treated with the following drugs: ferrostatin-1 (10 µM), liproxstatin-1 (10 µM), necrostatin-1 (20 µM for 2D and 30 µM for 3D), Zvad-fmk (25 µM for 2D or 40 µM for 3D). After 48 hours pretreatment, cell cultures or spheroids were incubated with PS-OR141 in the dark for 1 hour (2D) or 4 hours (3D) at the indicated concentrations, followed by a washing step. Photoactivation was performed using an LED light source for 60 min (2D) or 90 min (3D) and incubation was continued after the renewal of cell death inhibitors. ( A ) PDT-induced cytotoxicity over time in CT26 spheroids (cytotox green dye, Incucyte) in the presence of different cell death inhibitors. ( B, C ) Dose-response curves depicting the viability of CT26 and AB12 ( B ) 3D spheroid (propidium iodide measurement by flow cytometry) and ( C ) 2D cell monolayers (PrestoBlue) 48 hours and 24 hours post-PDT, respectively, in the presence of 10 µM ferrostatin-1. ( D ) Representative COX2, HSP70, MDA and β-actin immunoblots from CT26 spheroids collected 20 hours post-PDT. ( E ) Extracellular ATP release from CT26 spheroids (expressed as fold change) was determined 30 min post-PDT. ( F ) Heat map of LEGENDplex proinflammatory chemokines (13-plex) released by CT26 spheroids 3 hours post-PDT. N=2. ( G, H ) Prophylactic vaccination model. Mice were injected s.c. with 1×10 6 luc + AB1 2D cells exposed in vitro to photoactivated 100 nM PS-OR141 (or PBS as control) and challenged 1 week later with i.p. injection of live 1×10 6 luc + AB1 cells. ( G ) Tumor burden monitored by bioluminescence (expressed as photons/s/cm 2 /sr) and ( H ) corresponding survival curves. (**p≤0.01, N=8 mice per group). In vitro data ( B, C, E ) are plotted as the means±SEM from 3 independent experiments performed with ≥3 technical replicates (***p≤0.001; ****p≤0.0001; ns, p>0.05); when spheroids are involved, minimum of 6 spheroids were pooled together per condition. Significance was determined by one-way ANOVA with Tukey’s multiple comparison test. Log-rank (Mantel-Cox) test was used for survival curves. ANOVA, analysis of variance; i.p., intraperitoneal; PDT, photodynamic therapy.

Article Snippet: Bead-based immunoassays were analyzed using the NovoCyte Quanteon Flow Cytometer System (four lasers) with LEGENDplex Data Analysis Software Suite (Qognit).

Techniques: Incubation, Flow Cytometry, Western Blot, Injection, In Vitro, Control, Comparison

Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a LUNARIS assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.

Journal: Biomedicines

Article Title: Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis

doi: 10.3390/biomedicines10020420

Figure Lengend Snippet: Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a LUNARIS assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.

Article Snippet: Analysis of data was performed using LUNARIS Analysis Suite Software (Version 1.4, Ayoxxa, Cologne, Germany).

Techniques: Blocking Assay, Control, Concentration Assay